- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Mannan.
Displaying page 1 of 1.
EudraCT Number: 2020-004126-32 | Sponsor Protocol Number: T502-SIT-041 | Start Date*: 2020-12-18 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: A prospective open follow-up study with 10 000 mTU/mL mannan-conjugated birch pollen allergoids administered subcutaneously to participants of the T502-SIT-020 trial | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinitis or rhinoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003014-39 | Sponsor Protocol Number: MM09-SIT-040 | Start Date*: 2022-04-08 | ||||||||||||||||||||||||||
Sponsor Name:Inmunotek, S.L. | ||||||||||||||||||||||||||||
Full Title: Prospective, randomised, double-blind, double-dummy, placebo-controlled multicenter clinical trial of efficacy and safety with immunotherapy in patients with controlled mild to moderate allergic as... | ||||||||||||||||||||||||||||
Medical condition: Etiological treatment of mild to moderate controlled intermittent or persistent allergic asthma and intermittent or persistent allergic rhinitis / rhinoconjunctivitis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-004082-20 | Sponsor Protocol Number: T502-SIT-059 | Start Date*: 2023-03-07 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: An open phase III follow-up study in patients previously treated with mannan-conjugated birch pollen allergoids or placebo in the T502-045 trial. | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinoconjunctivitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003087-20 | Sponsor Protocol Number: 800_OPBG_2014 | Start Date*: 2014-11-12 | |||||||||||||||||||||
Sponsor Name:IRCCS Ospedale Pediatrico Bambino Gesù | |||||||||||||||||||||||
Full Title: Determination of Plasmatic and CSF Levels Of High Doses Of Micafungin in Neonates Suffering from Systemic Candidiasis and/or Candida meningitis. | |||||||||||||||||||||||
Medical condition: Systemic Candidiasis and/or Candida Meningitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002522-23 | Sponsor Protocol Number: T502-SIT-020 | Start Date*: 2019-08-21 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: A prospective, randomized, double-blind placebo-controlled dose-finding study of different regimens of mannan-conjugated allergoids of birch pollen allergens administered subcutaneously to patients... | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinitis or rhinoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002252-36 | Sponsor Protocol Number: T502-SIT-045 | Start Date*: 2021-10-27 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: A prospective, randomized, double-blind placebo-controlled multicentre study with 10 000 mTU/mL mannan-conjugated birch pollen allergoids administered subcutaneously to patients with birch pollen-i... | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinitis or rhinoconjunctivitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001472-22 | Sponsor Protocol Number: IMUNOR-201501 | Start Date*: 2017-03-14 | |||||||||||
Sponsor Name:ImunomedicA, a.s. | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Study Assessing Efficacy and Safety of the IMUNOR® Therapy Versus Placebo in Patients with Recurrent Vulvovaginit... | |||||||||||||
Medical condition: Recurrent vulvovaginitis episodes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.